New hope in the fight against RSV

Researchers discover promising drug candidate

13-Feb-2024 - The respiratory syncytial virus (RSV) causes severe lower respiratory tract infections, particularly in young children. To date, there is neither an antiviral therapy against the virus nor a vaccination for children. This is why researchers led by Thomas Pietschmann at TWINCORE, a joint ...

Computer-engineered DNA to study cell identities

“We can follow with our eyes the color in a petri dish when we give a treatment”

12-Feb-2024 - A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs, or to improve gene and cell-based ...

Innovative 3D drug screening system

Research project to develop a 3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties

11-May-2023 - Professor Timo Betz, University of Göttingen, has been awarded a Proof of Concept (PoC) grant by the European Research Council (ERC) for his “TissMec” project to develop a 3D screening system to cultivate tissue and automatically stimulate and quantify its mechanical properties. PoC ERC grants ...

Molecular Devices acquires Cellesce

“This enabling technology will make over 100,000 compound primary screens with PDOs a reality and will accelerate industry adoption of organoids”

19-Dec-2022 - Molecular Devices, LLC. announced the acquisition of Cellesce Ltd which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Drug efficacy and toxicity testing often rely on immortalized cell ...

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

New hope in the fight against unmet diseases

15-Dec-2022 - PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, announced a strategic research partnership aimed at advancing modern phenotypic drug ...

Semarion raises £2.14 million GBP seed funding

Semarion’s cell assaying platform turns adherent cells into liquid reagents to enable novel drug screening methodologies

24-Feb-2022 - Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced that it has closed a £2.14 million GBP seed funding round. The investment round was led by Parkwalk Advisors, ...

Insects’ sense of smell gives insight into better repellent design and drug screening

18-Aug-2021 - Skoltech researchers and their colleagues have studied a core element of the insect olfactory system to see how this knowledge might help in both fighting insects and using them to our advantage. The paper waspublishedin the journalMolecular Biology Reports. Olfaction, or the ability to detect ...

DESY X-ray lightsource identifies promising candidates for COVID drugs

Existing active substances bind to key virus protein

07-Apr-2021 - A team of researchers has identified several candidates for drugs against the coronavirus SARS-CoV-2 at DESY´s high-brilliance X-ray lightsource PETRA III. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. In a so-called X-ray screening, the ...

Functional drug screenings at a higher throughput

MaxWell Biosystems Completes CHF 4 million Series A Financing Round

18-Dec-2020 - MaxWell Biosystems AG, a spin-off from ETH Zürich founded in 2016 announced the closing of a CHF 4 million Series A financing round to further industrialize and scale-up the production of their consumables, so called multiwell high-density microelectrode array (HD-MEA) plates. Such scale-up will ...

Novel label-free biosensor platform for innovate modern drug screening

lino Biotech closes seed financing round

19-Nov-2020 - After almost a decade of initial invention and joint research on the Focal Molography technology at Roche, a leading player in the diagnostics and pharmaceutical area, and ETH Zurich as one of Europe’s most renowned research institutes, lino Biotech AG has licensed the technology to further ...